caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1124051560

James BerensonM.D.

PRACTICEJAMES R BERENSON, M.D., INCSee all providers at this practice →
Hematology-OncologyWest Hollywood, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 050625
Hospital
REFERRAL NETWORK

Where James Berenson's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 9 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Unilab Corporation
Clinical Laboratory · West Hills, CA
37519
Jonathan Said
Pathology · Los Angeles, CA
11383
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
CEDARS-SINAI MEDICAL CENTER1528,778
Unilab Corporation
Clinical Laboratory · West Hills, CA
38499
Laboratory Corporation Of America
Clinical Laboratory · San Diego, CA
18123
CEDARS-SINAI MEDICAL CENTER171,093
Anthony Bledin
Diagnostic Radiology · Oxnard, CA
17227
REGENTS UNIV OF CALIF LOS ANGELES15264
Jonathan Said
Pathology · Los Angeles, CA
13366
Shahrooz Eshaghian
Hematology-Oncology · Los Angeles, CA
12286
RAO, RAJEEV11138
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,773
Beneficiaries
—
Total drug cost
$10.7M
Distinct drugs
24
Brand share
51.0%
Top prescribed drugs
Isatuximab-Irfc291 claims
Acyclovir281 claims
Methylprednisolone254 claims
Denosumab106 claims
Pomalidomide97 claims
QUALITY · MIPS · 2024
Final MIPS score
88.6
Quality
67.2
Cost
48.3
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.57%
Individual
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,788
Unique beneficiaries
—
Total services
87,716
Distinct HCPCS
34
Medicare payment
$774K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — top quintile (cohort median 4,173).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$48K
Payment records
80
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$34K
Honoraria$5K
Consulting Fee$4K
Travel and Lodging$3K
Food and Beverage$2K